addressing the issues faced in the protect trial for patients with localized prostate cancer
Published 6 years ago • 208 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
0:59
protect trial: a battle between three treatments for patients with localized prostate cancer
-
2:48
10-year follow-up: the most effective treatment to protect patients with localized prostate cancer?
-
2:38
dr. mason discusses the protect study in localized prostate cancer
-
2:49
doctor explains the protect trial
-
6:57
phase ii trial of enoblituzumab for patients with intermediate/high-risk localised prostate cancer
-
4:12
active surveillance in localized prostate cancer
-
2:18
pros of the protect trial: is using data provided by patients a good tool for counselling?
-
0:46
protect trial overview
-
1:19
an ai biomarker to aid in the decision of treatment with adt for localized prostate cancer
-
2:44
the role of radiation in managing high-risk localized prostate cancer
-
14:14
trials in neoadjuvant therapy for patients with high-risk localized prostate cancer
-
1:14
rationale of phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
1:27
dr. zhang discusses the impact of the stampede trial in prostate cancer
-
5:21
prospective monitoring of patients with recurrent prostate cancer using serial psma imaging
-
6:12
neoadjuvant enoblituzumab for localized prostate cancer
-
1:54
dr. yu on the significance of the protect study in prostate cancer
-
20:52
aua/astro/suo guidelines on clinically localized prostate cancer
-
3:06
phase ii trial of nivolumab with soc in the management of gg5 prostate cancer
-
1:24
2-year toxicity update in pace-b for localised prostate cancer